标普和纳斯达克内在价值 联系我们

Merck & Co., Inc. MRK NYSE

NYSE • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score
83/100
7/7 Pass
SharesGrow Intrinsic Value
$187.77
+56.5%
Analyst Price Target
$128.54
+7.2%

Merck & Co., Inc. (MRK) has 20 已知的内部人和机构持有人记录. 最大持有人为 FRAZIER KENNETH C 持有 470,769 股. 其他重要持有人包括 Davis Robert M 和 DeLuca Richard R..

过去12个月,内部人进行了 74 笔交易,涉及 MRK 股票 — 48 笔买入 (价值为 $16.03M) 和 9 笔卖出 (价值为 $17.6M). 内部人买入超过卖出,可能表明对公司前景有信心.

MRK 內部人持股

最大持股人
FRAZIER KENNETH C
470,769 股
买入(12个月)
48
$16.03M 价值
卖出(12个月)
9
$17.6M 价值
12个月交易活动
买入 65%
卖出 12%
主要內部人持股
# 姓名 职位 持股数量 最近申报日期 相对规模
1 Frazier Kenneth C Executive Chair 470,769 2022-11-07
100%
2 Davis Robert M Chairman, CEO & President 443,602 2026-02-06
94%
3 Deluca Richard R. EVP&pres, Merck Animal Heallth 160,174 2026-02-06
34%
4 Perlmutter Roger M Exe V-p & Pres, Mrl 151,029 2020-05-05
32%
5 Wendell Peter C Director 124,753 2024-03-29
26%
6 Glocer Thomas H Director 108,293 2026-04-01
23%
7 Weeks Wendell P Director 92,486 2020-04-02
20%
8 Li Dean Y Executive VP & President, Mrl 92,035 2026-02-10
20%
9 Litchfield Caroline EVP & CFO 90,192 2026-01-28
19%
10 Lazarus Rochelle B Director 87,596 2020-04-02
19%
11 Zachary Jennifer EVP, General Counsel 68,916 2026-01-28
15%
12 Guindo Chirfi Chief Marketing Officer 60,615 2026-02-12
13%
13 Russo Patricia F Director 58,523 2025-06-03
12%
14 Brun Leslie A Director 49,719 2021-06-02
11%
15 Gerberding Julie L. EVP, Chief Patient Officer 48,712 2022-02-28
10%
16 Mizell Steven EVP, Chief HR Officer 41,319 2024-01-24
9%
17 Cech Thomas R Director 40,238 2020-06-02
9%
18 Clyburn Frank EVP & Pres ? Human Health 39,479 2021-11-04
8%
19 Rothman Paul Director 31,991 2025-06-03
7%
20 Craig Pamela J. Director 31,991 2025-06-03
7%
近期交易 (过去12个月)
日期 姓名 职位 类型 股数 股价 总价值
2026-03-31 Seidman Christine E Director 限制性股票授予 (RSU) 68 - -
2026-03-31 Coe Mary Ellen Director 限制性股票授予 (RSU) 249 - -
2026-03-31 Glocer Thomas H Director 限制性股票授予 (RSU) 405 - -
2026-03-02 Foard Brian Officer 未知 - - -
2026-02-12 Guindo Chirfi Chief Marketing Officer 知情卖出 10,000 $121.46 $1.21M
2026-02-10 Li Dean Y Executive VP & President, Mrl 知情卖出 10,235 $117.52 $1.2M
2026-02-09 Zachary Jennifer EVP, General Counsel 期权行权(卖出) 38,835 $87.10 $3.38M
2026-02-09 Guindo Chirfi Chief Marketing Officer 知情卖出 10,000 $118.41 $1.18M
2026-02-04 Smart Dalton E. Iii SVP Fin. - Global Controller 期权行权(卖出) 4,000 $62.07 $248.28K
2026-02-06 Oosthuizen Johannes Jacobus President, U.s. Market 知情卖出 15,000 $121.87 $1.83M
2026-02-04 Litchfield Caroline EVP & CFO 期权行权(卖出) 41,997 $53.06 $2.23M
2026-02-04 Li Dean Y Executive VP & President, Mrl 期权行权(卖出) 15,087 $56.04 $845.48K
2026-02-06 Williams David Michael EVP,chief Info&digital Officer 期权行权(卖出) 5,000 $77.62 $388.1K
2026-02-05 Guindo Chirfi Chief Marketing Officer 知情卖出 20,000 $121.88 $2.44M
2026-02-06 Deluca Richard R. EVP&pres, Merck Animal Heallth 知情卖出 37,685 $120.92 $4.56M
2026-02-04 Davis Robert M Chairman, CEO & President 知情卖出 32,462 $118.35 $3.84M
2026-01-26 Smart Dalton E. Iii SVP Fin. - Global Controller 限制性股票授予 (RSU) 1,066 $107.40 $114.49K
2026-01-26 Romanelli Joseph President, Human Health Int?l 限制性股票授予 (RSU) 5,703 $107.40 $612.5K
2026-01-26 Oosthuizen Johannes Jacobus President, U.s. Market 限制性股票授予 (RSU) 5,026 $107.40 $539.79K
2026-01-26 Litchfield Caroline EVP & CFO 限制性股票授予 (RSU) 15,852 $107.40 $1.7M
2026-01-26 Li Dean Y Executive VP & President, Mrl 限制性股票授予 (RSU) 20,469 $107.40 $2.2M
2026-01-26 Williams David Michael EVP,chief Info&digital Officer 限制性股票授予 (RSU) 6,112 $107.40 $656.43K
2026-01-26 Zachary Jennifer EVP, General Counsel 限制性股票授予 (RSU) 11,583 $107.40 $1.24M
2026-01-26 Guindo Chirfi Chief Marketing Officer 限制性股票授予 (RSU) 9,865 $107.40 $1.06M
2026-01-26 Chattopadhyay Sanat Exe V-p & Pres. Mmd 限制性股票授予 (RSU) 13,880 $107.40 $1.49M
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言